NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Adenovirus



National Institutes of Health publishes research in adenovirus



December 18th, 2007

Data detailed in 'Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus' have been presented. According to recent research from the United States, "Oncolytic adenoviruses as a treatment for cancer have demonstrated limited clinical activity. Contributing to this may be the relevance of preclinical animal models used to study these agents."

"Syngeneic mouse tumor models are generally non-permissive for adenoviral replication, whereas human tumor xenograft models exhibit attenuated immune responses to the vector. The cotton rat (Sigmodon hispidus) is susceptible to human adenovirus infection, permissive for...


Source: Cancer Weekly (2007-12-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login